PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 121 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $646,000 | +103.1% | 80,388 | +88.5% | 0.03% | +100.0% |
| Q1 2018 | $318,000 | +116.3% | 42,638 | +173.3% | 0.01% | +85.7% |
| Q1 2017 | $147,000 | -34.7% | 15,600 | -56.3% | 0.01% | -90.4% |
| Q3 2016 | $225,000 | -83.2% | 35,700 | -88.4% | 0.07% | +21.7% |
| Q1 2016 | $1,340,000 | +143.2% | 307,523 | +241.6% | 0.06% | +130.8% |
| Q4 2015 | $551,000 | +462.2% | 90,023 | +582.6% | 0.03% | +766.7% |
| Q2 2015 | $98,000 | – | 13,188 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 8,951,169 | $54,871,000 | 3.38% |
| Virtus ETF Advisers LLC | 103,807 | $636,000 | 1.75% |
| BKS ADVISORS, LLC | 291,150 | $1,785,000 | 0.92% |
| Piermont Capital Management Inc. | 363,549 | $2,229,000 | 0.71% |
| TUDOR INVESTMENT CORP ET AL | 2,370,760 | $14,532,000 | 0.41% |
| SEARLE & CO. | 60,000 | $349,000 | 0.34% |
| TURNER INVESTMENTS LLC | 252,785 | $1,550,000 | 0.32% |
| RICE HALL JAMES & ASSOCIATES, LLC | 891,672 | $5,466,000 | 0.31% |
| Phocas Financial Corp. | 635,333 | $3,895,000 | 0.30% |
| TFS CAPITAL LLC | 398,283 | $2,441,000 | 0.26% |